Curetis to Launch Multiplex MDx for Hospital Infections in U.S.
From - Diagnostic Testing & Emerging Technologies Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized… . . . read more
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article